Status:
COMPLETED
N-3 Fatty Acid Requirements for Human Development
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Pregnancy
Eligibility:
FEMALE
20-40 years
Phase:
PHASE1
Brief Summary
Polyunsaturated fatty acids known as n-3 fatty acids are essential dietary nutrients for humans, and are known to be important to reducing the risk of certain diseases, particularly those related to n...
Detailed Description
This is a randomized, blinded prospective study with 2 groups: placebo and group supplemented with DHA. Women are randomized at 16 weeks gestation without knowledge of their dietary fatty acid intake....
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- 12-16 weeks gestation
- Low risk pregnancy
- Expected to deliver single full term
- No maternal metabolic or infectious disease
- No known fetal complications.
Exclusion
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT00620672
Start Date
May 1 2004
End Date
May 1 2016
Last Update
June 1 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's & Women's Health Centre of British Columbia
Vancouver, British Columbia, Canada, V6H 3V4